Matthew Winton
Chief Commercial and Business · CervoMed Inc.
- 2024
- Oct 23, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Matthew Winton files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Joshua S. Boger - $3.00M in CRVO purchases and sales in the last 12 months
- Sylvie Gregoire - $283K in CRVO purchases and sales in the last 12 months
- John J. Alam - $283K in CRVO purchases and sales in the last 12 months
- William Robert Elder - $55K in CRVO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matthew Winton?
Matthew Winton is a corporate insider, tracked as Chief Commercial and Business of CervoMed Inc. (CRVO). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Matthew Winton submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Matthew Winton been buying or selling stock?
Recorded transactions: 3 open-market purchases ($117K) and 0 open-market sales across all tracked filings.
